Angiodynamics (ANGO) Change in Receivables (2010 - 2026)
Angiodynamics' (ANGO) quarterly Change in Receivables came in at $2.9 million in Q2 2026, up 749.44% YoY from $341754.3 in Q2 2025, and up 104.72% on a QoQ basis from $1.4 million in Q1 2026.
Angiodynamics (ANGO) Change in Receivables (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Change in Receivables data on file, last reported at $2.9 million in Q2 2026.
- Quarterly Change in Receivables rose 749.44% year-over-year to $2.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $5.8 million (up 25100.0% YoY) and the FY2026 annual result came in at $5.8 million, up 25100.0% from the prior year.
- Change in Receivables advanced to $2.9 million in Q2 2026, from $1.4 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $10.7 million in Q2 2022 to a low of -$5.5 million in Q2 2024.
- A 5-year average of $742277.8 and a median of $946000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables soared 3858.33% — and 2024, when it sank 369.63%.
- Tracing ANGO's Change in Receivables over 5 years: stood at -$406000.0 in 2022, then jumped by 710.84% to $2.5 million in 2023, then jumped by 50.56% to $3.7 million in 2024, then tumbled by 58.01% to $1.6 million in 2025, then soared by 85.14% to $2.9 million in 2026.
- The last three Change in Receivables figures came in at $2.9 million (Q2 2026), $1.4 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 74.90 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 37.21 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 2.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 252.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 156.00 Mn |
| 10 | Angiodynamics | 658.19 Mn | 604.32 Mn | 46.77 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 2.90 Mn |
| May 31, 2026 | 2.90 Mn |
| Feb 28, 2026 | 1.42 Mn |
| Feb 28, 2026 | 1.42 Mn |
| Nov 30, 2025 | 1.57 Mn |
| Nov 30, 2025 | 1.57 Mn |
| Aug 31, 2025 | -139,000.00 |
| Aug 31, 2025 | -139,000.00 |
| May 31, 2025 | -447,000.00 |
| May 31, 2025 | -447,000.00 |
| Feb 28, 2025 | 474,000.00 |
| Feb 28, 2025 | 474,000.00 |
| Nov 30, 2024 | 3.73 Mn |
| Nov 30, 2024 | 3.73 Mn |
| Aug 31, 2024 | -3.78 Mn |
| Aug 31, 2024 | -3.78 Mn |
| May 31, 2024 | -5.55 Mn |
| May 31, 2024 | -5.55 Mn |
| Feb 29, 2024 | -1.67 Mn |
| Feb 29, 2024 | -1.67 Mn |